Digest Network Come funziona
Network
/
Società
Ad
Non verificato

Aditxt, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteSanità

56 comunicati stampa

Guarda tutti i comunicati
05/03/2026
Finanza
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
18/11/2025
Tecnica
Salute
Finanza
Sanità
Associazioni/Professionisti
Oncologia
Scienza
Software
Titoli e azioni
Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, And Evofem’s Plan to Regain a National Listing
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
29/10/2025
Salute
Scienza
Farmaceutica
Biotecnologia
Finanza
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
27/10/2025
Sanità
Vetrine/Shopping
Salute
Medicina - Varie
Industria
Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
25/08/2025
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Industria
Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
11/08/2025
Associazioni/Professionisti
Salute
Biotecnologia
Mercato del lavoro
Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio™ Initiative
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
29/07/2025
Biotecnologia
Salute
Oncologia
Titoli e azioni
Mercato del lavoro
Aditxt’s Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for its Planned IPO Intending to Drive Clinical Validation and Commercial Rollout of Its Mitomic™ Platform Technology for Early Detection of Cancers and Other Diseases
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
24/07/2025
Oncologia
Salute
Vetrine/Shopping
Biotecnologia
Eventi
Industria
Aditxt’s Subsidiary Pearsanta Receives an Invitation to Submit Full Proposal for the U.S. Department of Defense Pilot Award for the Development of its Mitomic® Ovarian Test
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
22/07/2025
Biotecnologia
Salute
Scienza
Medicina - Varie
Web e Social Network
Eventi
Aditxt to Present at Wall Street Reporter’s Next Super Stock Livestream Today July 22, 2025, at 1 p.m. ET
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
07/07/2025
Biotecnologia
Finanza
Salute
Associazioni/Professionisti
Tecnica
Titoli e azioni
Aditxt Unveils bitXbio™: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech Commercialization
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0